0001179110-19-007875.txt : 20190619 0001179110-19-007875.hdr.sgml : 20190619 20190619160207 ACCESSION NUMBER: 0001179110-19-007875 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190617 FILED AS OF DATE: 20190619 DATE AS OF CHANGE: 20190619 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Turitz Andrew CENTRAL INDEX KEY: 0001726221 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 19906085 MAIL ADDRESS: STREET 1: C/O TELADOC, INC. STREET 2: 2 MANHATTANVILLE ROAD, SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 edgar.xml FORM 4 - X0306 4 2019-06-17 0 0001477449 Teladoc Health, Inc. TDOC 0001726221 Turitz Andrew C/O TELADOC HEALTH, INC. 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 0 1 0 0 SVP - Business Development Common Stock 2019-06-17 4 M 0 2840 12.21 A 6826 D Common Stock 2019-06-17 4 M 0 4167 22.30 A 10993 D Common Stock 2019-06-17 4 M 0 2150 38.55 A 13143 D Common Stock 2019-06-17 4 S 0 9157 60.05 D 3986 D Employee Stock Option (right to buy) 12.21 2019-06-17 4 M 0 2840 0.00 D 2026-03-07 Common Stock 2840 8522 D Employee Stock Option (right to buy) 22.30 2019-06-17 4 M 0 4167 0.00 D 2027-03-03 Common Stock 4167 29171 D Employee Stock Option (right to buy) 38.55 2019-06-17 4 M 0 2150 0.00 D 2028-03-01 Common Stock 2150 23650 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019. Represents the weighted average price of transactions ranging from $60.00 to $60.18. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. /s/ Adam C. Vandervoort, attorney-in-fact 2019-06-19